Resources & Evidence Contact us

607 Results:

Sort By:

Human breastmilk fortifiers may ward off eye disease in premature babies, finds Prolacta-backed study

Type: Prolacta in the News

Topic(s): Retinopathy of Prematurity (ROP)

Four studies showed Prolacta Bioscience’s 100% human milk-based fortifiers reduced retinopathy of prematurity (ROP) in premature infants

Type: Press Releases

Topic(s): Retinopathy of Prematurity (ROP)

Baby Crew achieves healthy growth with Prolacta's fortifiers

Type: Parent Stories

Topic(s): 22-27 weeks (extremely premature) Parents

Gloria Crockett, senior director of quality

Type: Employee Stories

Topic(s): Company Quality & Safety

Use of an exclusive human milk diet in preterm infants to lower healthcare costs – short-term and long-term perspectives

Type: Prolacta in the News

Topic(s): Cost Savings / Cost Effectiveness Long-Term outcomes Pasteurization

Prolacta Bioscience provides update on latest SARS-CoV-2 data and continued safety of its human milk-based nutritional products

Type: Press Releases

Topic(s): Quality & Safety

Prolacta’s manufacturing team shines in 2020

Type: Employee Stories

Topic(s): Quality & Safety

Donor Stephanie

Type: Donor Stories

Topic(s): Tiny Treasures

Donor Abbie gives back

Type: Donor Stories

Topic(s): Tiny Treasures

Not finding the reference you’re looking for?

Use our main search field or email us at info@prolacta.com